WO2000041463A3 - Nouveau traitement - Google Patents
Nouveau traitement Download PDFInfo
- Publication number
- WO2000041463A3 WO2000041463A3 PCT/EP1999/010295 EP9910295W WO0041463A3 WO 2000041463 A3 WO2000041463 A3 WO 2000041463A3 EP 9910295 W EP9910295 W EP 9910295W WO 0041463 A3 WO0041463 A3 WO 0041463A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hepatitis
- vaccine
- combination
- antiviral agents
- virus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Endocrinology (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU21009/00A AU760574B2 (en) | 1999-01-12 | 1999-12-21 | Novel treatment |
BR9916893-6A BR9916893A (pt) | 1999-01-12 | 1999-12-21 | Tratamento |
HU0105070A HUP0105070A2 (hu) | 1999-01-12 | 1999-12-21 | Hepatitis B vírus fertőzések megelőzésére és kezelésére szolgáló készlet |
IL14418699A IL144186A0 (en) | 1999-01-12 | 1999-12-21 | Novel treatment |
EP99965531A EP1140163A2 (fr) | 1999-01-12 | 1999-12-21 | Nouveau traitement |
KR1020017008833A KR20010090011A (ko) | 1999-01-12 | 1999-12-21 | 신규 처리 |
JP2000593088A JP2002534438A (ja) | 1999-01-12 | 1999-12-21 | 新規治療法 |
PL99349347A PL349347A1 (en) | 1999-01-12 | 1999-12-21 | Novel treatment |
CA002359110A CA2359110A1 (fr) | 1999-01-12 | 1999-12-21 | Nouveau traitement |
NZ512890A NZ512890A (en) | 1999-01-12 | 1999-12-21 | Antiviral agents including nucleoside analogues active against hepatitis B virus (HBV) |
NO20013337A NO20013337L (no) | 1999-01-12 | 2001-07-05 | Ny behandling |
HK02101211.9A HK1041434A1 (zh) | 1999-01-12 | 2002-02-19 | 抗病毒藥物和乙型肝炎疫苗的聯合 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9900630 | 1999-01-12 | ||
GB9900630.6 | 1999-01-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000041463A2 WO2000041463A2 (fr) | 2000-07-20 |
WO2000041463A3 true WO2000041463A3 (fr) | 2000-11-09 |
Family
ID=10845878
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1999/010295 WO2000041463A2 (fr) | 1999-01-12 | 1999-12-21 | Nouveau traitement |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP1140163A2 (fr) |
JP (1) | JP2002534438A (fr) |
KR (1) | KR20010090011A (fr) |
CN (1) | CN1391482A (fr) |
AR (1) | AR022250A1 (fr) |
AU (1) | AU760574B2 (fr) |
BR (1) | BR9916893A (fr) |
CA (1) | CA2359110A1 (fr) |
CO (1) | CO5241355A1 (fr) |
CZ (1) | CZ20012544A3 (fr) |
HK (1) | HK1041434A1 (fr) |
HU (1) | HUP0105070A2 (fr) |
IL (1) | IL144186A0 (fr) |
NO (1) | NO20013337L (fr) |
NZ (1) | NZ512890A (fr) |
PL (1) | PL349347A1 (fr) |
TR (1) | TR200102024T2 (fr) |
WO (1) | WO2000041463A2 (fr) |
ZA (1) | ZA200105690B (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999061056A2 (fr) | 1998-05-22 | 1999-12-02 | Loeb Health Research Institute At The Ottawa Hospital | Methodes et produits permettant d'induire une immunite au niveau des muqueuses |
CN1560078B (zh) | 1998-07-31 | 2011-06-22 | 株式会社国际癌症免疫研究所 | 基于癌抑制基因wt1的产物的癌抗原 |
CA2440303C (fr) | 2001-03-22 | 2013-03-19 | Haruo Sugiyama | Peptide modifie wt1 |
US8735357B2 (en) | 2001-09-28 | 2014-05-27 | International Institute Of Cancer Immunology, Inc. | Method of inducing antigen-specific T cells |
JPWO2003028758A1 (ja) * | 2001-09-28 | 2005-01-13 | 治夫 杉山 | 抗原特異的t細胞の誘導方法 |
MY131488A (en) * | 2002-04-08 | 2007-08-30 | Bristol Myers Squibb Co | Low dose liquid entecavir formulations and use |
PT2241325E (pt) | 2002-10-29 | 2012-04-12 | Coley Pharm Gmbh | Utilização de oligonucleótidos cpg no tratamento de infecção com vírus da hepatite c |
AU2003300919A1 (en) | 2002-12-11 | 2004-06-30 | Coley Pharmaceutical Gmbh | 5' cpg nucleic acids and methods of use |
CN100443117C (zh) * | 2003-05-13 | 2008-12-17 | 深圳康泰生物制品股份有限公司 | 一种治疗性乙型肝炎的疫苗制剂、其制备方法及其用途 |
US8541167B2 (en) | 2004-06-03 | 2013-09-24 | Saint Louis University | Methods and compositions for vaccination |
AR065504A1 (es) * | 2007-02-28 | 2009-06-10 | Ct Ingenieria Genetica Biotech | Terapia combinada para el tratamiento de la hepatitis b cronica. uso. |
WO2020134682A1 (fr) * | 2018-12-24 | 2020-07-02 | 南京远大赛威信生物医药有限公司 | Préparation pharmaceutique pour le traitement de l'hépatite b, procédé de préparation s'y rapportant et utilisation associée |
EP4321173A1 (fr) * | 2021-04-07 | 2024-02-14 | Denka Company Limited | Activateur d'activité d'adjuvant et composition d'adjuvant |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0414374A2 (fr) * | 1989-07-25 | 1991-02-27 | Smithkline Biologicals S.A. | Antigènes ainsi que les méthodes pour leur préparation |
WO1999045957A2 (fr) * | 1998-03-09 | 1999-09-16 | Smithkline Beecham Biologicals S.A. | Compositions de vaccins combines |
-
1999
- 1999-12-21 PL PL99349347A patent/PL349347A1/xx not_active Application Discontinuation
- 1999-12-21 KR KR1020017008833A patent/KR20010090011A/ko not_active Application Discontinuation
- 1999-12-21 CN CN99816471A patent/CN1391482A/zh active Pending
- 1999-12-21 CZ CZ20012544A patent/CZ20012544A3/cs unknown
- 1999-12-21 AU AU21009/00A patent/AU760574B2/en not_active Ceased
- 1999-12-21 TR TR2001/02024T patent/TR200102024T2/xx unknown
- 1999-12-21 EP EP99965531A patent/EP1140163A2/fr not_active Withdrawn
- 1999-12-21 HU HU0105070A patent/HUP0105070A2/hu unknown
- 1999-12-21 IL IL14418699A patent/IL144186A0/xx unknown
- 1999-12-21 JP JP2000593088A patent/JP2002534438A/ja active Pending
- 1999-12-21 WO PCT/EP1999/010295 patent/WO2000041463A2/fr not_active Application Discontinuation
- 1999-12-21 CA CA002359110A patent/CA2359110A1/fr not_active Abandoned
- 1999-12-21 BR BR9916893-6A patent/BR9916893A/pt not_active IP Right Cessation
- 1999-12-21 NZ NZ512890A patent/NZ512890A/en unknown
-
2000
- 2000-01-11 AR ARP000100107A patent/AR022250A1/es not_active Application Discontinuation
- 2000-01-12 CO CO00001261A patent/CO5241355A1/es not_active Application Discontinuation
-
2001
- 2001-07-05 NO NO20013337A patent/NO20013337L/no not_active Application Discontinuation
- 2001-07-11 ZA ZA200105690A patent/ZA200105690B/xx unknown
-
2002
- 2002-02-19 HK HK02101211.9A patent/HK1041434A1/zh unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0414374A2 (fr) * | 1989-07-25 | 1991-02-27 | Smithkline Biologicals S.A. | Antigènes ainsi que les méthodes pour leur préparation |
WO1999045957A2 (fr) * | 1998-03-09 | 1999-09-16 | Smithkline Beecham Biologicals S.A. | Compositions de vaccins combines |
Non-Patent Citations (8)
Title |
---|
BERENGUER M ET AL: "Hepatitis B and C viruses: Molecular identification and targeted antiviral therapies", PROCEEDINGS ASSOCIATION OF AMERICAN PHYSICIANS, vol. 110, no. 2, March 1998 (1998-03-01), pages 98 - 112, XP000909240 * |
BONI C ET AL: "Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B [see comments].", JOURNAL OF CLINICAL INVESTIGATION, (1998 SEP 1) 102 (5) 968-75., XP000909082 * |
GROB P J: "Hepatitis B: virus, pathogenesis and treatment", VACCINE,GB,BUTTERWORTH SCIENTIFIC. GUILDFORD, vol. 16, no. 1001, November 1998 (1998-11-01), pages S11 - S16, XP004150417, ISSN: 0264-410X * |
MOLLOY P J ET AL: "Combined interferon, famciclovir and GM-CSF treatment of HBV infection in an individual with periarteritis nodosa.", HEPATO-GASTROENTEROLOGY, (1999 JUL-AUG) 46 (28) 2529-31., XP000909277 * |
PIANKO S. ET AL: "Chronic hepatitis B: New therapies on the horizon?.", LANCET, (13 NOV 1999) 354/9191 (1662-1663)., XP000906960 * |
RUDD, JENNIFER N. (1) ET AL: "Possible role for hepatitis B vaccine after lamivudine rescue for severe acute hepatitis B.", GASTROENTEROLOGY, (APRIL, 1999) VOL. 116, NO. 4 PART 2, PP. A1268. MEETING INFO.: DIGESTIVE DISEASE WEEK AND THE 100TH ANNUAL MEETING OF THE AMERICAN GASTROENTEROLOGICAL ASSOCIATION ORLANDO, FLORIDA, USA MAY 16-19, 1999 AMERICAN GASTROENTEROLOGICAL A, XP000909262 * |
SUK-FONG LOK A.: "Hepatitis B infection: Pathogenesis and management.", JOURNAL OF HEPATOLOGY, SUPPLEMENT, (2000) 32/1 (89-97)., XP000909278 * |
VALDEZ H ET AL: "Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen. ACTG 375 team. AIDS Clinical Trials Group.", AIDS, (2000 JAN 7) 14 (1) 11-21., XP000909260 * |
Also Published As
Publication number | Publication date |
---|---|
KR20010090011A (ko) | 2001-10-17 |
TR200102024T2 (tr) | 2001-12-21 |
EP1140163A2 (fr) | 2001-10-10 |
CZ20012544A3 (cs) | 2002-01-16 |
AR022250A1 (es) | 2002-09-04 |
JP2002534438A (ja) | 2002-10-15 |
HK1041434A1 (zh) | 2002-07-12 |
NO20013337L (no) | 2001-08-17 |
PL349347A1 (en) | 2002-07-15 |
IL144186A0 (en) | 2002-05-23 |
ZA200105690B (en) | 2002-09-25 |
NO20013337D0 (no) | 2001-07-05 |
WO2000041463A2 (fr) | 2000-07-20 |
AU2100900A (en) | 2000-08-01 |
CA2359110A1 (fr) | 2000-07-20 |
CO5241355A1 (es) | 2003-01-31 |
NZ512890A (en) | 2003-09-26 |
BR9916893A (pt) | 2001-11-20 |
HUP0105070A2 (hu) | 2002-04-29 |
AU760574B2 (en) | 2003-05-15 |
CN1391482A (zh) | 2003-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS20120201A3 (en) | METHODS AND MIXTURES FOR TREATMENT OF VIRAL HEPATITIS C | |
CA2253490A1 (fr) | Utilisation d'il-12 ifn-.alpha. pour le traitement de maladies infectieuses | |
DE60030293D1 (de) | Harnstoffsubstituierte imidazochinoline | |
BR0111195A (pt) | Uso de b-l-2'-desoxi-nucleosìdeos no tratamento de infecção por vìrus de hepatite delta | |
IL215891A (en) | Hepatitis C Serine Protease Inhibitors, Pharmaceutical Compounds Containing Them, and Their Use in Preparing Drugs to Treat Hepatitis C Infections | |
IL143512A (en) | Azabicycloalkanes, pharmaceuticals including them and their use in the manufacture of drugs for the prevention or treatment of infection by the immunodeficiency virus | |
WO2000041463A3 (fr) | Nouveau traitement | |
IL139002A0 (en) | Compositions for the treatment of hiv and other viral infections | |
CA2433878A1 (fr) | Derives de nucleoside comme inhibiteurs de l'arn polymerase virale arn-dependante | |
HUP0300121A3 (en) | Macrocyclic peptides active against the hepatitis c virus, process for preparation and pharmaceutical compositions containing them | |
EE04850B1 (et) | Pürimidiini derivaatide kasutamine ravimi valmistamiseks, mis on ette nähtud HIV nakkuse raviks, ühend, seda sisaldav farmatseutiline kompositsioon, meetod ühendi ja kompositsiooni valmistamiseks ning kombineeritud preparaat kasutamiseks HIV nakku | |
GEP20104960B (en) | USE OF [D-MeALa]3-[EtVal]4-CYCLOSPORIN FOR THE TREATMENT OF HEPATITIS C INFECTION AND PHARMACEUTICAL COMPOSITION COMPRISING SAID [D-MeAla]3-[EtVal]4-CYCLOSPORIN | |
WO2003051306A3 (fr) | Nucleosides de n4-acylcytosine-1,3-dioxolane destines au traitement d'infections virales | |
HUP0202502A2 (hu) | Virális fertőzőképességet blokkoló peptidek és eljárások ezek alkalmazására | |
WO2002092006A3 (fr) | Composes a base d'acides nucleiques et procedes d'utilisation associes | |
EA200100494A1 (ru) | Синтез 1,3-оксаселеноланнуклеозидов, обладающих активностью против вируса иммунодефицита человека и против вируса гипатита-b | |
AU2002219881A1 (en) | Methods and compositions for the treatment of human immunodeficiency virus infection | |
ZA991029B (en) | Composition and methods for treatment of hiv infections. | |
WO1999051256A3 (fr) | Utilisation de l-glu-l-trp pour le traitement d'une infection par vih | |
WO2001010454A3 (fr) | Composition et procedes de traitement d'infection par le vih | |
HUP0200679A2 (en) | Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients | |
AU2002323443A1 (en) | Compositions and methods for the diagnosis and treatment of herpes simplex virus infection | |
DE60016044D1 (de) | Eisenchelator enthaltende antivirale pharmazeutische zusammensetzungen | |
ZA200108398B (en) | Anti-HIV-1 vaccine comprising all or part of the HIV-1 Tat protein. | |
WO2004064784A3 (fr) | Preparation et methode de prevention ou de traitement d'une infection virale |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 99816471.2 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
ENP | Entry into the national phase |
Ref document number: 2000 593088 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 144186 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999965531 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2359110 Country of ref document: CA Ref document number: 2359110 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 21009/00 Country of ref document: AU Ref document number: IN/PCT/2001/969/CHE Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 512890 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020017008833 Country of ref document: KR Ref document number: PA/a/2001/007112 Country of ref document: MX Ref document number: PV2001-2544 Country of ref document: CZ Ref document number: 2001/02024 Country of ref document: TR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09869998 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1999965531 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020017008833 Country of ref document: KR |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: PV2001-2544 Country of ref document: CZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 21009/00 Country of ref document: AU |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999965531 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1020017008833 Country of ref document: KR |
|
WWR | Wipo information: refused in national office |
Ref document number: PV2001-2544 Country of ref document: CZ |